These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38629257)

  • 1. ΔNp73 and its effector targets promote colorectal peritoneal carcinosis and predict survival.
    Pastor-Morate D; Amigo-Morán L; Garranzo-Asensio M; Rejas-González R; Carnicero P; Rodríguez N; Pérez-Robledo JP; Barderas R; Prieto-Nieto I; Domínguez G
    J Pathol; 2024 Jul; 263(3):328-337. PubMed ID: 38629257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting carcinoma-associated mesothelial cells with antibody-drug conjugates in ovarian carcinomatosis.
    Pascual-Antón L; Sandoval P; González-Mateo GT; Kopytina V; Tomero-Sanz H; Arriero-País EM; Jiménez-Heffernan JA; Fabre M; Egaña I; Ferrer C; Simón L; González-Cortijo L; Sainz de la Cuesta R; López-Cabrera M
    J Pathol; 2023 Oct; 261(2):238-251. PubMed ID: 37555348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.
    Rynne-Vidal A; Au-Yeung CL; Jiménez-Heffernan JA; Pérez-Lozano ML; Cremades-Jimeno L; Bárcena C; Cristóbal-García I; Fernández-Chacón C; Yeung TL; Mok SC; Sandoval P; López-Cabrera M
    J Pathol; 2017 Jun; 242(2):140-151. PubMed ID: 28247413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional molecules in mesothelial-to-mesenchymal transition revealed by transcriptome analyses.
    Namvar S; Woolf AS; Zeef LA; Wilm T; Wilm B; Herrick SE
    J Pathol; 2018 Aug; 245(4):491-501. PubMed ID: 29774544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis.
    Sandoval P; Jiménez-Heffernan JA; Rynne-Vidal Á; Pérez-Lozano ML; Gilsanz Á; Ruiz-Carpio V; Reyes R; García-Bordas J; Stamatakis K; Dotor J; Majano PL; Fresno M; Cabañas C; López-Cabrera M
    J Pathol; 2013 Dec; 231(4):517-31. PubMed ID: 24114721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ΔNp73 status in peritoneal and ovarian dissemination of appendicular adenocarcinoids (goblet cells).
    Prieto-Nieto MI; Pastor D; Rodríguez-Cobos J; Pérez JP; Méndez C; Palacios E; Arranz-Alvarez M; Santos-López J; Cano-Vega M; Viñal D; Rodríguez N; Domínguez G
    Clin Transl Oncol; 2019 Oct; 21(10):1432-1439. PubMed ID: 31025168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition.
    Li Q; Li B; Li Q; Wei S; He Z; Huang X; Wang L; Xia Y; Xu Z; Li Z; Wang W; Yang L; Zhang D; Xu Z
    Cell Death Dis; 2018 Aug; 9(9):854. PubMed ID: 30154401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options.
    Sluiter N; de Cuba E; Kwakman R; Kazemier G; Meijer G; Te Velde EA
    Clin Exp Metastasis; 2016 Jun; 33(5):401-16. PubMed ID: 27074785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CILP2 is a potential biomarker for the prediction and therapeutic target of peritoneal metastases in colorectal cancer.
    Ha YJ; Park SH; Tak KH; Lee JL; Kim CW; Kim JH; Kim SY; Kim SK; Yoon YS
    Sci Rep; 2024 May; 14(1):12487. PubMed ID: 38816545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-to-mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition.
    McCorry AM; Loughrey MB; Longley DB; Lawler M; Dunne PD
    J Pathol; 2018 Dec; 246(4):422-426. PubMed ID: 30105762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SPOCD1-AS from ovarian cancer extracellular vesicles remodels mesothelial cells to promote peritoneal metastasis via interacting with G3BP1.
    Wang C; Wang J; Shen X; Li M; Yue Y; Cheng X; Lu W; Wang X; Xie X
    J Exp Clin Cancer Res; 2021 Mar; 40(1):101. PubMed ID: 33726799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer.
    Mukai S; Oue N; Oshima T; Imai T; Sekino Y; Honma R; Sakamoto N; Sentani K; Kuniyasu H; Egi H; Tanabe K; Yoshida K; Ohdan H; Yasui W
    J Pathol; 2017 Sep; 243(1):100-110. PubMed ID: 28671736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the peritoneal microenvironment in the pathogenesis of colorectal peritoneal carcinomatosis.
    Demuytere J; Ceelen W; Van Dorpe J; Hoorens A
    Exp Mol Pathol; 2020 Aug; 115():104442. PubMed ID: 32305340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Sluiter NR; de Cuba EM; Kwakman R; Meijerink WJ; Delis-van Diemen PM; Coupé VM; Beliën JA; Meijer GA; de Hingh IH; te Velde EA
    Clin Exp Metastasis; 2016 Apr; 33(4):297-307. PubMed ID: 26873137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical
    Weidle UH; Brinkmann U; Auslaender S
    Cancer Genomics Proteomics; 2020; 17(5):453-468. PubMed ID: 32859626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
    Narasimhan V; Britto M; Pham T; Warrier S; Naik A; Lynch AC; Michael M; Tie J; Ramsay R; Heriot A
    Dis Colon Rectum; 2019 Oct; 62(10):1195-1203. PubMed ID: 31490828
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Gomez LC; Sottile ML; Guerrero-Gimenez ME; Zoppino FCM; Redondo AL; Gago FE; Orozco JI; Tello OM; Roqué M; Nadin SB; Marzese DM; Vargas-Roig LM
    J Clin Pathol; 2018 Jan; 71(1):52-58. PubMed ID: 28743687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum.
    Nakamura M; Ono YJ; Kanemura M; Tanaka T; Hayashi M; Terai Y; Ohmichi M
    Gynecol Oncol; 2015 Nov; 139(2):345-54. PubMed ID: 26335595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD31 and D2-40 Contribute to Peritoneal Metastasis of Colorectal Cancer by Promoting Epithelial-Mesenchymal Transition.
    Zhu X; Zhou G; Ni P; Jiang X; Huang H; Wu J; Shi X; Jiang X; Liu J
    Gut Liver; 2021 Mar; 15(2):273-283. PubMed ID: 32390409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer-promoting activity of the senescent peritoneal mesothelium.
    Mikuła-Pietrasik J; Sosińska P; Maksin K; Kucińska MG; Piotrowska H; Murias M; Woźniak A; Szpurek D; Książek K
    Oncotarget; 2015 Oct; 6(30):29178-95. PubMed ID: 26284488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.